Medicare Spending on Drugs With Accelerated Approval, 2015-2019.
Where this comes from
- Record sourced from PubMed, PMID 35977299.
- Also identified by DOI 10.1001/jamahealthforum.2021.3937 and PMC identifier 8796889.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This article examines the budgetary implications of high-priced accelerated approval drugs by estimating Medicare spending on these drugs from 2015 through 2019.
Medical subject headings
- Medicare